Letco Medical Considers Patient Safety Its Highest Priority And Supports The FDA's Warning Concerning The Inappropriate Use Of Glutathione Powder In Compounded Sterile Injectable Formulations

WAYNE, Pa., Feb. 1, 2019 /PRNewswire/ -- On February 1, 2019, the Federal Food and Drug Administration (FDA) issued a public statement warning compounders "not to use glutathione-L-reduced powder distributed by Letco Medical, Decatur, Alabama, to compound sterile injectable drugs for...

from PR Newswire: https://prn.to/2Tq7Wew